サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1266630

ヘビ抗毒素の世界市場規模調査＆予測、タイプ別（多価異種、一価異種）、用途別（病院、診療所）、地域分析、2022-2029年

Global Snake Antivenom Market Size study & Forecast, by Type ( Polyvalent Heterologous, Monovalent Heterologous) by Application ( Hospitals, Clinics), and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ヘビ抗毒素の世界市場規模調査＆予測、タイプ別（多価異種、一価異種）、用途別（病院、診療所）、地域分析、2022-2029年
出版日: 2023年04月24日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヘビ抗毒素市場は、2021年に約2億9,480万米ドルと評価され、予測期間2022-2029年には7.7%以上の健全な成長率で成長すると予測されています。

抗毒素は、ヘビに噛まれた後に人間に起こる免疫反応を高めることで機能します。抗毒素は、蛇の毒を羊や馬などのドナー動物に注射することで製造されます。免疫系が強く、蛇毒成分に結合できる強固な抗体が生成されることで、動物自身の自然な防御力により毒素を排除することができます。ヘビ毒市場は、ヘビ咬傷の発生率の増加や意識向上のための政府の取り組みの高まりなどの要因によって拡大しています。

熱帯・亜熱帯地域では、ヘビ咬傷は最も注目されていない健康問題です。世界保健機関（WHO）は、世界規模で年間270万件の蛇の毒咬症が記録されていると推定しています。毒咬傷は、年間81,000～138,000人の死亡の原因となっていると考えられています。これらの相互作用の地理的な分布は大きく異なります。アジアだけでも、年間約170万件の蛇咬傷事件が報告されています。また、アフリカやラテンアメリカの国々でも、毎年、かなりの数の蛇咬傷が発生しています。世界的に蛇の咬傷事故が増加している主な原因の1つは、新規製品のニーズがあり、市場成長を牽引していることです。また、ヘビに刺されたときの症状を効果的に消すことができる唯一の薬が「抗毒素」です。蛇の毒薬は基本的な医療行為の一部であり、WHOの「必須医薬品」にも含まれています。さらに、いくつかの政府や非政府組織が、ヘビ刺されによる致死率を下げるために、ヘビ刺され治療の普及のための多くのプロジェクトや取り組みを開始しました。2030年までにヘビ咬傷による障害や死亡者数を減らすために、WHOは2019年5月に「蛇咬傷防止と制御のための戦略」を発表しました。これらの取り組みは、低・中所得国でのアクセシビリティの向上や認知度の向上に、これらの団体の支援を受けています。しかし、適切な価格規制と償還政策の欠如は、2022年から2029年の予測期間を通じて市場の成長を阻害しています。

ヘビ抗毒素の世界市場調査において考慮した主要地域は、アジア太平洋地域、北米、欧州、中南米、世界のその他の地域です。北米は、主要プレイヤーの存在と政府当局による調査イニシアティブにより、収益面で市場を独占しています。一方、アジア太平洋は、蛇の毒殺の増加、研究開発のための共同研究の増加、主要企業の地理的拡大、政府機関や非営利団体の市場参入などの要因から、予測期間中に最も高いCAGRで成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、競合情勢や主要企業の製品に関する詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推定・予測、2019年～2029年
    • ヘビ抗毒素市場、地域別、2019-2029年
    • ヘビ抗毒素市場、タイプ別、2019-2029年
    • ヘビ抗毒素市場、用途別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 ヘビ抗毒素の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 ヘビ抗毒素の世界市場力学

  • ヘビ抗毒素市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • ヘビ噛まれる被害が増加中
      • 意識改革に向けた政府の取り組みが活発化
    • 市場の課題
      • 適切な価格規制と診療報酬政策の欠如
    • 市場機会
      • 新興国市場における市場プレイヤーの浸透度向上

第4章 ヘビ抗毒素の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • ソーシャル
    • テクニカル
  • 主な投資機会
  • 主要成功戦略
  • 業界関係者見通し
  • アナリストの提言と結論

第5章 リスク評価：COVID-19の影響

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 ヘビ抗毒素の世界市場：タイプ別

  • マーケットスナップショット
  • ヘビ抗毒素の世界市場：種類別、実績-ポテンシャル分析
  • ヘビ抗毒素の世界市場タイプ別推定・予測2019-2029
  • ヘビ抗毒素市場、サブセグメント別分析
    • 多価異種
    • 一価異種

第7章 ヘビ抗毒素の世界市場：用途別

  • マーケットスナップショット
  • ヘビ抗毒素の世界市場：用途別、実績-潜在能力分析
  • ヘビ抗毒素の世界市場推定・予測（アプリケーション別） 2019-2029
  • ヘビ抗毒素市場、サブセグメント別分析
    • 病院
    • クリニック

第8章 ヘビ抗毒素の世界市場：地域別分析

  • ヘビ抗毒素市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプ別の推定・予測、2019年～2029年
      • アプリケーション別の推定・予測、2019年～2029年
    • カナダ
  • 欧州ヘビ抗毒素市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋のヘビ抗毒素市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカヘビ抗毒素市場スナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第9章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • MicroPharm
      • 主要な情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • BTG International Inc.
    • VINS Bioproducts Limited
    • Pfizer Inc.
    • SEQIRUS（CSL Limited）
    • Inosan Biopharma
    • South Africa Vaccine Producers
    • Rare Disease Therapeutics, Inc.
    • Incepta Vaccine Ltd.
    • Bioclon Institute

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Snake Antivenom Market, report scope
  • TABLE 2. Global Snake Antivenom Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Snake Antivenom Market estimates & forecasts by Type 2019-2029 (USD Million)
  • TABLE 4. Global Snake Antivenom Market estimates & forecasts by Application 2019-2029 (USD Million)

a. Global Snake Antivenom Market by segment, estimates & forecasts, 2019-2029 (USD Million)

  • TABLE 5. Global Snake Antivenom Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 6. Global Snake Antivenom Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global Snake Antivenom Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Snake Antivenom Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Snake Antivenom Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Snake Antivenom Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Snake Antivenom Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Snake Antivenom Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Snake Antivenom Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. U.S. Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. U.S. Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 16. U.S. Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 17. Canada Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 18. Canada Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. Canada Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 20. UK Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 21. UK Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. UK Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 23. Germany Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 24. Germany Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. Germany Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 26. France Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 27. France Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. France Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 29. Italy Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 30. Italy Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. Italy Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 32. Spain Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 33. Spain Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Spain Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 35. RoE Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 36. RoE Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. RoE Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 38. China Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 39. China Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. China Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 41. India Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 42. India Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. India Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 44. Japan Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 45. Japan Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. Japan Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 47. South Korea Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 48. South Korea Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. South Korea Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 50. Australia Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 51. Australia Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. Australia Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 53. RoAPAC Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 54. RoAPAC Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. RoAPAC Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 56. Brazil Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 57. Brazil Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. Brazil Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 59. Mexico Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 60. Mexico Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Mexico Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 62. RoLA Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 63. RoLA Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. RoLA Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 65. Row Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 66. Row Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. Row Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 68. List of secondary sources, used in the study of global Snake Antivenom Market
  • TABLE 69. List of primary sources, used in the study of global Snake Antivenom Market
  • TABLE 70. Years considered for the study
  • TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Snake Antivenom Market, research methodology
  • FIG 2. Global Snake Antivenom Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Snake Antivenom Market, key trends 2021
  • FIG 5. Global Snake Antivenom Market, growth prospects 2022-2029
  • FIG 6. Global Snake Antivenom Market, porters 5 force model
  • FIG 7. Global Snake Antivenom Market, pest analysis
  • FIG 8. Global Snake Antivenom Market, value chain analysis
  • FIG 9. Global Snake Antivenom Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Snake Antivenom Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Snake Antivenom Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Snake Antivenom Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Snake Antivenom Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Snake Antivenom Market, regional snapshot 2019 & 2029
  • FIG 15. North America Snake Antivenom Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Snake Antivenom Market 2019 & 2029 (USD Million)
  • FIG 17. Asia pacific Snake Antivenom Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Snake Antivenom Market 2019 & 2029 (USD Million)
  • FIG 19. Global Snake Antivenom Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Snake Antivenom Market is valued at approximately USD 294.8 million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.7% over the forecast period 2022-2029. Antivenoms work by boosting the immunological response that occurs in humans after being bitten by a snake. They are made by injecting snake venom into donor animals like sheep or horses. Strong immune systems and the generation of robust antibodies that can attach to snake venom components in these animals enable their own natural defenses to eliminate these toxins.. The Snake Antivenom market is expanding because of factors such as the rising incidence of snakebites and rising government initiatives to raise awareness.

In tropical and subtropical areas, snakebites are the health issue that receives the least attention. The World Health Organization (WHO) estimates that 2.7 million cases of snake envenoming are recorded annually on a global scale. Venomous bites are thought to be the cause of 81,000 to 138,000 fatalities annually. The geographic distribution of these interactions varies greatly. In Asia alone, there are almost 1.7 million snakebite incidents reported per year. Each year, a significant number of snakebites occur in nations in Africa and Latin America as well. One of the main causes of the worldwide increase in snake envenoming incidents is the need for novel products, driving market growth. Additionally, the only medication that may effectively undo the symptoms of snake envenoming is antivenom. Snake's antivenom is a component of basic medical care and is included among the "Essential Medicines" by the WHO. Furthermore, several government and non-government organizations started a number of projects and initiatives to spread the word about snakebite treatment in an effort to lower the fatality rate from snakebites. In order to reduce the number of disabilities and fatalities by snakebites by the year 2030, the WHO launched a strategy for preventing and controlling snakebite envenoming in May 2019. These initiatives have aided these organizations in increasing accessibility and raising awareness in low- and middle-income nations. However, the Lack of adequate price regulation and reimbursement policy stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Snake Antivenom Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the presence of key players, and research initiatives by government authorities. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as increasing snake envenoming's, an increase in the number of collaborations for research and development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:

  • MicroPharm Ltd
  • BTG International Inc.
  • VINS Bioproducts Limited
  • Pfizer Inc.
  • SEQIRUS (CSL Limited)
  • Inosan Biopharma
  • South Africa Vaccine Producers
  • Rare Disease Therapeutics, Inc.
  • Incepta Vaccine Ltd.
  • Bioclon Institute

Recent Developments in the Market:

  • In January 2019, BTG International Inc. collaborated with OMNY to increase the usability of its snake antivenom CroFab through distributed ledger technology.
  • In November 2020, CSL Sequris (a CSL Limited subsidiary) financed over USD 601.5 million in building a manufacturing facility in the Southern Hemisphere to produce Australian antivenoms, as well as the Q-fever vaccine and pandemic flu vaccine.

Global Snake Antivenom Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Polyvalent Heterologous
  • Monovalent Heterologous

By Type:

  • Hospitals
  • Clinics

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Snake Antivenom Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Snake Antivenom Market, by Type, 2019-2029 (USD Million)
    • 1.2.3. Snake Antivenom Market, by Application, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Snake Antivenom Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Snake Antivenom Market Dynamics

  • 3.1. Snake Antivenom Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising Incidence of Snakebites
      • 3.1.1.2. Rising government initiatives to raise awareness
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of adequate price regulation and reimbursement policy
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising Penetration by Market Players in Developing Nations

Chapter 4. Global Snake Antivenom Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Snake Antivenom Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Snake Antivenom Market by Type, Performance - Potential Analysis
  • 6.3. Global Snake Antivenom Market Estimates & Forecasts by Type 2019-2029 (USD Million)
  • 6.4. Snake Antivenom Market, Sub Segment Analysis
    • 6.4.1. Polyvalent Heterologous
    • 6.4.2. Monovalent Heterologous

Chapter 7. Global Snake Antivenom Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Snake Antivenom Market by Application, Performance - Potential Analysis
  • 7.3. Global Snake Antivenom Market Estimates & Forecasts by Application 2019-2029 (USD Million)
  • 7.4. Snake Antivenom Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Clinics

Chapter 8. Global Snake Antivenom Market, Regional Analysis

  • 8.1. Snake Antivenom Market, Regional Market Snapshot
  • 8.2. North America Snake Antivenom Market
    • 8.2.1. U.S. Snake Antivenom Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Snake Antivenom Market
  • 8.3. Europe Snake Antivenom Market Snapshot
    • 8.3.1. U.K. Snake Antivenom Market
    • 8.3.2. Germany Snake Antivenom Market
    • 8.3.3. France Snake Antivenom Market
    • 8.3.4. Spain Snake Antivenom Market
    • 8.3.5. Italy Snake Antivenom Market
    • 8.3.6. Rest of Europe Snake Antivenom Market
  • 8.4. Asia-Pacific Snake Antivenom Market Snapshot
    • 8.4.1. China Snake Antivenom Market
    • 8.4.2. India Snake Antivenom Market
    • 8.4.3. Japan Snake Antivenom Market
    • 8.4.4. Australia Snake Antivenom Market
    • 8.4.5. South Korea Snake Antivenom Market
    • 8.4.6. Rest of Asia Pacific Snake Antivenom Market
  • 8.5. Latin America Snake Antivenom Market Snapshot
    • 8.5.1. Brazil Snake Antivenom Market
    • 8.5.2. Mexico Snake Antivenom Market
    • 8.5.3. Rest of Latin America Snake Antivenom Market
  • 8.6. Rest of The World Snake Antivenom Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. MicroPharm
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. BTG International Inc.
    • 9.2.3. VINS Bioproducts Limited
    • 9.2.4. Pfizer Inc.
    • 9.2.5. SEQIRUS (CSL Limited)
    • 9.2.6. Inosan Biopharma
    • 9.2.7. South Africa Vaccine Producers
    • 9.2.8. Rare Disease Therapeutics, Inc.
    • 9.2.9. Incepta Vaccine Ltd.
    • 9.2.10. Bioclon Institute

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption